SEC Form 4 research
| Issuer | Akari Therapeutics Plc |
|---|---|
| Tickers | AKTX, CLTX |
| Reporting owners | 34 |
| Officers and directors | 2 |
| Last public filing | 2026-10-14 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-14 | 2026-10-12 | Vat-Ho Vatnak | A | 87,000 | $0 | Not reported |
| 2026-10-01 | 2026-09-29 | Gaslightwala Abizer | A | 6,430 | $9.72 | Not reported |
| 2026-08-19 | 2026-08-17 | Farag Kameel D. | A | 1,728 | $7.52 | Not reported |
| 2026-08-05 | 2026-07-16 | Farag Kameel D. | A | 1,130 | $11.5 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.